The independent source for health policy research, polling, and news.
81 - 100 of 1,299 Results
Secretary Robert F. Kennedy Jr.’s HHS said an enormous, noncompetitive flu vaccine development grant to two favored NIH leaders would ensure “transparency, effectiveness, and comprehensive preparedness.” But their vaccine is in early stages, relies on old technology, and is just one of scores of similar efforts.
The Department of Health and Human Services underwent an unprecedented purge this week, as thousands of employees from the National Institutes of Health, the FDA, the Centers for Disease Control and Prevention, and other agencies were fired, placed on administrative leave, or offered transfers to far-flung Indian Health Service facilities. Altogether, the layoffs mean the federal government, in a single day, shed hundreds if not thousands of combined years of health and science expertise. Lauren Weber of The Washington Post, Rachel Cohrs Zhang of Bloomberg News, and Sarah Karlin-Smith of the Pink Sheet join KFF Health News’ Julie Rovner to discuss this enormous breaking story and more. Also this week, Rovner interviews KFF Health News’ Julie Appleby, who reported and wrote the latest “Bill of the Month” feature about a short-term health plan and a very expensive colonoscopy.
The rate of overdose deaths from opioids has grown significantly among Black people. Yet, even after a nonfatal overdose, this group is half as likely to be referred to or get treatment compared with white people. Advocates and researchers cite implicit bias, insurance denials, and other systemic issues.
A bill designed to force PBMs to pay higher fees to independent drugstores sailed through the state House, but lobbyists are marshaling their forces to kill the measure in the Senate.
It’s the Trump administration vs. the federal courts, as the Department of Government Efficiency continues to try to cancel federal contracts and programs and fire workers. But in the haste to cut things, jobs and programs are being eliminated even if they align with the new administration’s goal to “Make America Healthy Again.” Jessie Hellmann of CQ Roll Call, Sarah Karlin-Smith of the Pink Sheet, and Rachel Roubein of The Washington Post join KFF Health News’ Julie Rovner to discuss these stories and more.
Two senior scientists say National Institutes of Health officials advised them to remove references to mRNA vaccines in grant applications, and they fear the Trump administration will abandon a promising field of medical research.
The FDA is already limited in policing claims of health benefits by makers of supplements and herbal remedies — a $70 billion industry. Get ready for even less regulation.
KFF Health News journalists made the rounds on national and local media recently to discuss topical stories. Here’s a collection of their appearances.
Pain MD, which once ran as many as 20 clinics across three states, gave chronic-pain patients about 700,000 total injections near their spines, according to court documents. Last year, federal prosecutors proved at trial that the shots were medically unnecessary and part of an extensive fraud scheme.
Frustrated by spiraling drug costs, California lawmakers want to increase oversight of pharmaceutical industry intermediaries known as pharmacy benefit managers. It’s unclear whether they can persuade Gov. Gavin Newsom to get on board.
From rolling back drug pricing policies to limiting gender-affirming care, President Donald Trump signed several health-related executive orders in the first hours of his second presidency. Here’s a roundup of the changes and what they mean.
The federal government has allocated $1.15 billion to long-covid research without any new treatments yet brought to market. Patients and scientists say it’s time to push harder for breakthroughs.
As Gov. Gavin Newsom enters the second half of his final term, health care stands out as his most ambitious but glaringly incomplete initiative for California residents. The issue will likely shape his national profile for better or worse. And now, Donald Trump brings a new wrinkle.
Since 2018, readers and listeners sent KFF Health News-NPR’s “Bill of the Month” thousands of questionable bills. Our crowdsourced investigation paved the way for landmark legislation and highlighted cost-saving strategies for all patients.
Donald Trump’s first administration advanced rules forcing hospitals and insurers to reveal prices for medical services. Employers don’t want to risk backtracking during Trump’s second administration.
KFF Health News gives readers a chance to comment on a recent batch of stories.
As criticism of pharmacy benefit managers heats up, fear of lawsuits is driving some big employers to drop the “Big Three” PBMs — or force them to change.
The outpouring of anger at health insurers following the killing of UnitedHealthcare CEO Brian Thompson continues a cycle of rage that dates back decades.
GLP-1 agonist medications such as Ozempic accounted for 10% of the North Carolina state employee health plan’s prescription drug spending, so the state is no longer covering them for weight loss alone. Still, it did decide to cover them for Medicaid patients’ weight loss. A look inside the state’s coverage calculus.
© 2026 KFF